scholarly journals Glucose Control, Disease Burden, and Educational Gaps in People With Type 1 Diabetes: Exploratory Study of an Integrated Mobile Diabetes App

JMIR Diabetes ◽  
2018 ◽  
Vol 3 (4) ◽  
pp. e17 ◽  
Author(s):  
Cornelis J Tack ◽  
Gerardus J Lancee ◽  
Barend Heeren ◽  
Lucien JLPG Engelen ◽  
Sandra Hendriks ◽  
...  
2017 ◽  
Author(s):  
Cornelis J Tack ◽  
Gerardus J Lancee ◽  
Barend Heeren ◽  
Lucien JLPG Engelen ◽  
Sandra Hendriks ◽  
...  

BACKGROUND Self-monitoring and self-management, crucial for optimal glucose control in type 1 diabetes, requires many disease-related decisions per day and imposes a substantial disease burden on people with diabetes. Innovative technologies that integrate relevant measurements may offer solutions that support self-management, decrease disease burden, and benefit diabetes control. OBJECTIVE The objective of our study was to evaluate a prototype integrated mobile phone diabetes app in people with type 1 diabetes. METHODS In this exploratory study, we developed an app that contained cloud-stored log functions for glucose, carbohydrates (including a library), insulin, planned exercise, and mood, combined with a bolus calculator and communication functions. Adults with diabetes tested the app for 6 weeks. We assessed the feasibility of app use, user experiences, perceived disease burden (through questionnaires), insulin dose and basal to bolus ratio, mean glucose level, hemoglobin A1c, and number of hypoglycemic events. RESULTS A total of 19 participants completed the study, resulting in 5782 data entries. The most frequently used feature was logging blood glucose, insulin, and carbohydrates. Mean diabetes-related emotional problems (measured with the Problem Areas in Diabetes scale) scores decreased from 14.4 (SD 10.0) to 12.2 (SD 10.3; P=.04), and glucose control improved, with hemoglobin A1c decreasing from 7.9% (mean 62.3, SD 8 mmol/mol) to 7.6% (mean 59.8, SD 7 mmol/mol; P=.047). The incidence of hypoglycemic events did not change. Participants were generally positive about the app, rating it as “refreshing,” and as providing structure by reinforcing insulin-dosing principles. The app revealed substantial knowledge gaps. Logged data enabled additional detailed analyses. CONCLUSIONS An integrated mobile diabetes app has the potential to improve diabetes self-management and provide tailored educational support, which may decrease disease burden and benefit diabetes control.


Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 983-P
Author(s):  
SUE A. BROWN ◽  
BRUCE W. BODE ◽  
CAROL J. LEVY ◽  
GREGORY P. FORLENZA ◽  
BRUCE A. BUCKINGHAM ◽  
...  

2019 ◽  
Author(s):  
Arkadiusz Michalak ◽  
Konrad Pagacz ◽  
Wojciech Młynarski ◽  
Agnieszka Szadkowska ◽  
Wojciech Fendler

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Chun-xiu Gong ◽  
Li-ya Wei ◽  
Di Wu ◽  
Bing-yan Cao ◽  
Xi Meng ◽  
...  

Aims. To determine whether multiple daily injections (MDIs) or continuous subcutaneous insulin infusion (CSII) contributes to better glucose control in children with different type 1 diabetes duration.Methods. Subjects were grouped according to early (≤1 year after disease onset; 1A) or late (1–3 years after onset; 2A) MDIs/CSII treatment initiation. Corresponding control groups (1B, 2B) received insulin injections twice daily.Results. HbA1c levels were consistently lower in group 1A than in group 1B (6 months (T2): 7.37% versus 8.21%; 12 months (T3): 7.61% versus 8.41%; 24/36 months (T4/T5): 7.61% versus 8.72%; allP<0.05), but were lower in group 2A than in group 2B only at T2 (8.36% versus 9.19%;P=0.04). Levels were lower in group 1A than in group 2A when disease duration was matched (7.61% versus 8.49%;P<0.05). Logistic regression revealed no correlation between HbA1c level and MDIs/CSII therapy. HbA1c levels were only negatively related to insulin dosage.Conclusions. Blood glucose control was better in patients receiving MDIs/CSII than in those receiving conventional treatment. Early MDIs/CSII initiation resulted in prolonged maintenance of low HbA1c levels compared with late initiation. MDIs/CSII therapy should be combined with comprehensive management.


2000 ◽  
Vol 50 ◽  
pp. 220-221
Author(s):  
M Pein ◽  
J Deibler ◽  
P Roach ◽  
J Woodworth ◽  
U Gudat ◽  
...  

1990 ◽  
Vol 7 (8) ◽  
pp. 695-699 ◽  
Author(s):  
B.H.R. Wolffenbuttel ◽  
B.M. Ouwerkerk ◽  
B.F.E. Veldhuyzen ◽  
P.H.L.M. Geelhoed-Duijvestijn ◽  
G. Jakobsen ◽  
...  

Diabetologia ◽  
2017 ◽  
Vol 60 (11) ◽  
pp. 2157-2167 ◽  
Author(s):  
Klemen Dovc ◽  
Maddalena Macedoni ◽  
Natasa Bratina ◽  
Dusanka Lepej ◽  
Revital Nimri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document